These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 16215282)
1. Proceedings from the 1st Seminar on Cardiovascular Engineering: Medical Engineering and Therapy. 27-28 April 2004, Nancy, France. Clin Hemorheol Microcirc; 2005; 33(3):165-308. PubMed ID: 16215282 [No Abstract] [Full Text] [Related]
2. Proceedings of the 3rd International Meeting on Medical Engineering and Therapy. May 15-16, 2006. Nancy, France. Biomed Mater Eng; 2008; 18(1 Suppl):S1-118. PubMed ID: 18533324 [No Abstract] [Full Text] [Related]
3. Proceedings from the symposium Cell Therapy, Bioengineering and Regenerative Medicine, September 2008, Nancy, France. Biomed Mater Eng; 2009; 19(4-5):269-379. PubMed ID: 20310080 [No Abstract] [Full Text] [Related]
4. Proceedings of the 5th Scientific Meeting on Cartilage Engineering, February 4-5, 2010, Vandoeuvre-lès-Nancy, France. Biomed Mater Eng; 2010; 20(3):119-242. PubMed ID: 21351386 [No Abstract] [Full Text] [Related]
5. Tissue engineering therapy for cardiovascular diseases. Tiwari A; Hamilton G; Seifalian AM Circ Res; 2003 Jul; 93(2):e1. PubMed ID: 12881476 [No Abstract] [Full Text] [Related]
11. A Multidisciplinary and Multicultural Adventure: From Materials Engineering to Cardiovascular Science. Serpooshan V Circ Res; 2017 May; 120(10):1540-1541. PubMed ID: 28495987 [No Abstract] [Full Text] [Related]
12. Cellular therapy and myocardial tissue engineering: the role of adult stem and progenitor cells. Wu KH; Liu YL; Zhou B; Han ZC Eur J Cardiothorac Surg; 2006 Nov; 30(5):770-81. PubMed ID: 16963271 [TBL] [Abstract][Full Text] [Related]
13. Current progress in 3D printing for cardiovascular tissue engineering. Mosadegh B; Xiong G; Dunham S; Min JK Biomed Mater; 2015 Mar; 10(3):034002. PubMed ID: 25775166 [TBL] [Abstract][Full Text] [Related]
14. Chemical and physical regulation of stem cells and progenitor cells: potential for cardiovascular tissue engineering. Huang NF; Lee RJ; Li S Tissue Eng; 2007 Aug; 13(8):1809-23. PubMed ID: 17518703 [TBL] [Abstract][Full Text] [Related]
15. Papers from the 5th Scientific Meeting on Cartilage Engineering, February 2010, Nancy, France. Foreword. Stoltz JF; Magdalou J; Netter P; Pinzano A Biomed Mater Eng; 2010; 20(3):119. PubMed ID: 20930318 [No Abstract] [Full Text] [Related]
16. [Interventional Cardiology. Proceedings of High Tech 2004 Conference. 28-30 January 2004, Marseille, France]. Ann Cardiol Angeiol (Paris); 2004 Sep; 53(5):221-89. PubMed ID: 15959959 [No Abstract] [Full Text] [Related]
17. Nano-biomaterials for cardiovascular applications: Clinical perspective. Cicha I; Singh R; Garlichs CD; Alexiou C J Control Release; 2016 May; 229():23-36. PubMed ID: 26988601 [TBL] [Abstract][Full Text] [Related]
18. Other approaches to fighting cardiovascular disease: stem cells and engineered tissue. Mason C Med Device Technol; 2006; 17(1):26-7. PubMed ID: 16483108 [TBL] [Abstract][Full Text] [Related]
19. Microtensile testing of collagen fibril for cardiovascular tissue engineering. Wang X; Li X; Yost MJ J Biomed Mater Res A; 2005 Aug; 74(2):263-8. PubMed ID: 15962267 [TBL] [Abstract][Full Text] [Related]
20. Economics and Cost-Effectiveness in Evaluating the Value of Cardiovascular Therapies. Proceedings of a symposium. St. Petersburg, Florida, USA. April 17-20, 1997. Am Heart J; 1999 May; 137(5):S35-144. PubMed ID: 10366362 [No Abstract] [Full Text] [Related] [Next] [New Search]